Press releas­es

News Articles

1. Press releases, Kanvas Bio

   07, Nov, 2024

   Kan­vas Bio Unveils Clin­i­cal Data on the Gut Microbiome’s Impact on Anti-Tumoral Immu­ni­ty at SITC

2. Press releases, Kanvas Bio

   01, Jul, 2024

   With $12.5M in New Fund­ing, Kan­vas Bio is Advanc­ing its Nov­el, Micro­bio­me-Based, Immuno-oncol­o­gy Drug Candidates

3. Press releases, Kanvas Bio

   21, Jun, 2024

   Intro­duc­ing the Next Drug Can­di­date in Kan­vas Bio’s Immuno-Oncol­o­gy Pro­gram: KAN-003

4. Press releases, Kanvas Bio

   11, Oct, 2023

   Kan­vas Bio­sciences Acquires Fed­er­a­tion Bio Assets

5. Press releases, PR Newswire

   22, Jun, 2023

   Kan­vas Clos­es $12M Fund­ing Round